National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 75825 [05-24309]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 244 / Wednesday, December 21, 2005 / Notices
Review Branch, Division of Extramural
Activities, National Institute of Dental &
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892–6402, 301–593–
4861, peter.zelazowski@nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 06–28, Review T32s.
Date: January 25, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Courtyard BWI Airport
Hotel, 1671 West Nursery Road, Linthicum,
MD 21090.
Contact Person: Lynn M. King, PhD.,
Scientific Review Administrator, Scientific
Review Branch, 45 Center Dr., Rm 4AN—
32F, National Institution of Dental &
Craniofacial Research, National Institutes of
Health, Bethesda, MD 20892–6402, 301–594–
5006, lynn.king@nih.gov.
Name of Committee: National Institute of
Dental and Craniofacial Research Special
Emphasis Panel 06–39, Review of R21s
(Perio/Micro).
Date: March 22, 2006.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Bethesda,
MD 20892.
Contact Person: Yujing Liu, MD, PhD.,
Scientific Review Administrator, National
Institute of Dental & Craniofacial Research,
45 Center Drive, Natcher Building, Room.
4AN38E, Bethesda, MD 20892, (301) 594–
3169, yujing_liu@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.121, Oral Diseases and
Disorders Research, National Institutes of
Health, HHS)
Dated: December 12, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–24308 Filed 12–20–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
erjones on PROD1PC68 with NOTICES
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
VerDate Aug<31>2005
15:25 Dec 20, 2005
Jkt 208001
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, R21—Innovative Grants on
Immune Tolerance.
Date: January 9–10, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Paul A. Amstad, PhD.,
Scientific Review Administrator, Scientific
Review Program, Division of Extramural
Activities, NIH/NIAID/DHHS, 6700B
Rockledge Drive, MSC 7616, Bethesda, MD
20892–7616, (301) 402–7098,
pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 12, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–24309 Filed 12–20–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice
is hereby given of the following
meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Unsolicited R01
Application.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
75825
Date: January 11, 2006.
Time: 3:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call).
Contact Person: Leyla S. Diaz, PhD.,
Scientific Review Administrator, Scientific
Review Program, NIH/NIAID/DEAS/DHHS,
Room 2217, 6700B Rockledge Drive, MSC–
7616, Bethesda, MD 20892–7616, 301–496–
2550, diazl@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: December 12, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–24310 Filed 12–20–05; 8:45 am]
BILLING CODE 4140–01–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal and Skin Diseases;
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (U.S.C. Appendix 2), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commerical
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel. Research
Project (R01).
Date: January 9, 2006.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892. (Telephone
Conference Call).
Contact Person: Yan Z. Wang, PhD., MD,
Scientific Review Administrator, National
Institute of Arthritis and Musculoskeletal and
Skin Diseases, 6701 Democracy Blvd., Suite
820, Bethesda, MD 20892. (301) 594–4957.
wangy1@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.846, Arthritis,
E:\FR\FM\21DEN1.SGM
21DEN1
]]>Agencies
[Federal Register Volume 70, Number 244 (Wednesday, December 21, 2005)]
[Notices]
[Page 75825]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-24309]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, R21--Innovative Grants on Immune
Tolerance.
Date: January 9-10, 2006.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Paul A. Amstad, PhD., Scientific Review
Administrator, Scientific Review Program, Division of Extramural
Activities, NIH/NIAID/DHHS, 6700B Rockledge Drive, MSC 7616,
Bethesda, MD 20892-7616, (301) 402-7098, pamstad@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: December 12, 2005.
Anna Snouffer,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 05-24309 Filed 12-20-05; 8:45 am]
BILLING CODE 4140-01-M
